EP Patent

EP2903615B1 — 5-pyridin-3-yl-2,3-dihydro-1h-indole derivatives as aldosterone synthase (cyp11b2) inhibitors for the treatment of hypertension

Assigned to ElexoPharm GmbH · Expires 2021-04-07 · 5y expired

What this patent protects

Patent listed against osilodrostat-phosphate.

Drugs covered by this patent

osilodrostat-phosphate (OSILODROSTAT PHOSPHATE)

Patent Metadata

Patent number: EP2903615B1
Jurisdiction: EP
Classification: —
Expires: 2021-04-07
Drug substance claim: No
Drug product claim: No
Assignee: ElexoPharm GmbH
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.